Amber Scorah | 05/31/2011
The role of CROs in the drug discovery process is constantly evolving, and as data management and distribution efforts improve, there is increased opportunity for leveraging CROs within Drug Discovery research.
In this podcast, Rose Gonzales, Director at Pfizer, talks about the ever changing role of CROs, and the evolving relationship between CROs and CMI.
Have Your Say
Rate this feature and give us your feedback in the comments section below...
To continue reading this story Click Here
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More